Wells Fargo & Company Castle Biosciences Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Castle Biosciences Inc stock. As of the latest transaction made, Wells Fargo & Company holds 11,915 shares of CSTL stock, worth $340,888. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,915

Previous 11,507 3.55%

Holding current value

$340,888

Previous $250,000 35.6%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$17.4 - $31.47 $7,099 - $12,839	408 Added 3.55%	11,915 $339,000
Q2 2024 Aug 13, 2024	BUY	$18.84 - $24.94 $39,206 - $51,900	2,081 Added 22.08%	11,507 $250,000
Q1 2024 May 10, 2024	BUY	$18.06 - $25.3 $26,710 - $37,418	1,479 Added 18.61%	9,426 $208,000
Q4 2023 Feb 09, 2024	BUY	$12.19 - $22.43 $18,845 - $34,676	1,546 Added 24.15%	7,947 $171,000
Q3 2023 Nov 13, 2023	SELL	$13.28 - $20.3 $66,546 - $101,723	-5,011 Reduced 43.91%	6,401 $108,000
Q2 2023 Aug 15, 2023	BUY	$11.66 - $26.0 $65,039 - $145,028	5,578 Added 95.61%	11,412 $156,000
Q1 2023 May 12, 2023	SELL	$19.47 - $28.49 $355,269 - $519,857	-18,247 Reduced 75.77%	5,834 $132,000
Q4 2022 Feb 13, 2023	BUY	$18.08 - $30.0 $361,220 - $599,370	19,979 Added 487.06%	24,081 $566,000
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $18,863 - $28,760	838 Added 25.67%	4,102 $107,000
Q2 2022 Aug 12, 2022	SELL	$16.0 - $45.99 $1.62 Million - $4.65 Million	-101,099 Reduced 96.87%	3,264 $71,000
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $111,418 - $157,805	-3,359 Reduced 3.12%	104,363 $4.68 Million
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $18.1 Million - $31.3 Million	-462,813 Reduced 81.12%	107,722 $4.62 Million
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $3.79 Million - $4.89 Million	62,997 Added 12.41%	570,535 $37.9 Million
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $318,094 - $487,783	-6,353 Reduced 1.24%	507,538 $37.2 Million
Q1 2021 May 13, 2021	SELL	$58.92 - $97.33 $4.55 Million - $7.52 Million	-77,215 Reduced 13.06%	513,891 $35.2 Million
Q4 2020 Feb 09, 2021	SELL	$43.6 - $73.05 $541,730 - $907,646	-12,425 Reduced 2.06%	591,106 $39.7 Million
Q3 2020 Nov 05, 2020	BUY	$38.47 - $52.03 $1.77 Million - $2.4 Million	46,058 Added 8.26%	603,531 $31.1 Million
Q2 2020 Aug 13, 2020	BUY	$27.28 - $43.01 $8.1 Million - $12.8 Million	296,960 Added 113.99%	557,473 $21 Million
Q1 2020 May 14, 2020	BUY	$23.08 - $35.53 $6.01 Million - $9.26 Million	260,513 New	260,513 $7.77 Million

Others Institutions Holding CSTL

# of Institutions

201

Shares Held

24.5M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $752M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Castle Biosciences Inc Transaction History